TERT-BUTYL 4-(2-(BOC-AMINO)ETHYL)BENZOATE, 97.0%, 1g

tert-Butyl 6-oxo-3-azabicyclo[3.1.1]heptane-3-carboxylate, 95.0%, 10g

4-Hydroxyphenylacetic Acid>99.0%(GC)(T)500g

2-Hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 10g

Tanshinone IIA, 97.0%, 250mg

(2E)-1-(4-ethylphenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g

tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate, 95.0%, 250mg

4-CHLORO-7-METHYL-5,7-DIHYDRO-6H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE, 95.0%, 5g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

1,3-Dichloro-2-fluoro-5-iodobenzene, 98.0%, 1g

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 5g

4-(Bis(4-fluorophenyl)methylene)piperidine, 95.0%, 100mg

2,7-dimethylquinoline-4-carboxylic acid, 95.0%, 100mg